6-(1-(8-fluoro-6-(1-methyl-1H-pyrazol-4-yl)-(1,2,4)triazolo(4,3-a)pyridin-3-yl)ethyl)-3-(2-methoxyethoxy)-1,6-naphthyridin-5(6H)-one,
AMG 337,
AMG-337,
AMG-337,
1173699-31-4,
AMG 337,
UNII-08WG8S0L8D,
08WG8S0L8D,
CHEMBL3785909,
1,6-Naphthyridin-5(6H)-one, 6-[(1R)-1-[8-fluoro-6-(1-methyl-1H-pyrazol-4-yl)-1,2,4-triazolo[4,3-a]pyridin-3-yl]ethyl]-3-(2-methoxyethoxy)-,
1,6-Naphthyridin-5(6H)-one, 6-((1R)-1-(8-fluoro-6-(1-methyl-1H-pyrazol-4-yl)-1,2,4-triazolo(4,3-a)pyridin-3-yl)ethyl)-3-(2-methoxyethoxy)-,
SCHEMBL4304600,
AMG 337 [WHO-DD],
KS-00001DDD,
BCP16602,
BDBM50157612,
MFCD29472283,
s8167,
ZINC144562400,
CS-5281,
SB19194,
NCGC00483923-01,
HY-18696,
A16400,
J-690042,
(r)-6-(1-(8-fluoro-6-(1-methyl-1h-pyrazol-4-yl)-[1,2,4]triazolo[4,3-a]pyridin-3-yl)ethyl)-3-(2-methoxyethoxy)-1,6-naphthyridin-5(6h)-one,
6-[(1R)-1-[8-fluoro-6-(1-methyl-1H-pyrazol-4-yl)-[1,2,4]triazolo[4,3-a]pyridin-3-yl]ethyl]-3-(2-methoxyethoxy)-5,6-dihydro-1,6-naphthyridin-5-one,
Evacetrapib,
AMG337,
6-[(1~{r})-1-[8-Fluoranyl-6-(1-Methylpyrazol-4-Yl)-[1,2,4]triazolo[4,3-A]pyridin-3-Yl]ethyl]-3-(2-Methoxyethoxy)-1,6-Naphthyridin-5-One,